CalciMedica is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO A. Rachel Leheny, with a market cap of $10.2M.
Common questions about CalciMedica
CalciMedica is scheduled to report earnings for Q1 2026 on May 13, 2026.
CalciMedica has approximately 13 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.